The amygdala is a medial temporal lobe region that plays a central role in the acquisition and expression of Pavlovian conditioned fear^[@R1]-[@R3]^. The amygdala contains multiple anatomically defined nuclei^[@R4]^. Associative learning largely occurs in the lateral nucleus (LA), while the central nucleus (CEA) is thought to control the expression of fear^[@R5],[@R6]^. However CEA contains at least 3 subnuclei (CEm, CEl and capsular CE)^[@R3],[@R4]^ and multiple neuronal subtypes^[@R7]-[@R10]^, the role of which is poorly understood. A full understanding of amygdala function requires its dissection at the cellular level.

Here we have used genetic methods to investigate the functional connectivity and behavioral relevance of a GABAergic subpopulation within CEl^[@R11]-[@R13]^, marked by expression of protein kinase C-δ (PKCδ). These neurons inhibit output neurons in CEm, and also make reciprocal inhibitory connections with PKCδ^−^ neurons within CEl. Genetic silencing^[@R14],[@R15]^ in conjunction with in vivo electrophysiology indicates that these neurons likely correspond to "CEl~off~" units identified by Ciocchi et al.^[@R16]^, that are inhibited by the conditioned stimulus (CS). Taken together, these data define the functional connectivity and behavioral relevance of an inhibitory microcircuit within CEl^[@R9],[@R17]^, that gates output from CEm^[@R12]^.

Properties of PKCδ^+^ neurons in CEl {#S1}
====================================

We sought stable markers for CEA subpopulations^[@R18],[@R19]^, which could be used to genetically manipulate their activity in vivo^[@R20]-[@R22]^. PKCδ marks ∼50% of CEl GABAergic neurons ([Fig. 1a-d](#F1){ref-type="fig"} and [Table S1](#SD1){ref-type="supplementary-material"}). These neurons are distinct from those expressing corticotropin releasing hormone^[@R9]^ (CRH; [Fig. 1e-g](#F1){ref-type="fig"}) or dynorphin^[@R10]^ (Dyn; [Fig. S1a-c](#SD1){ref-type="supplementary-material"}), while ∼40% express enkephalin^[@R9]^ (Enk; [Fig. 1h-j](#F1){ref-type="fig"} and [Table S1](#SD1){ref-type="supplementary-material"}) and ∼65% express the oxytocin receptor (OxtR; [Fig. S1d-f and Table S1](#SD1){ref-type="supplementary-material"}), which is implicated in inhibitory gating of CEm^[@R12]^.

We examined the electrophysiological properties of PKCδ^+^ neurons in acute amygdala slices. Due to their low spontaneous activity, spiking was evoked by injection of depolarizing current. This analysis confirmed three types of neurons: late-firing, regular spiking, and low-threshold bursting neurons^[@R23]^ ([Fig. 1k, l](#F1){ref-type="fig"} and [Table S2](#SD1){ref-type="supplementary-material"}). Neurobiotin fills and antibody staining, as well as recording from fluorescently labeled PKCδ^+^ neurons in transgenic mice (see below) indicated that most PKCδ^+^ neurons are late-firing ([Fig. 1m, o](#F1){ref-type="fig"} and [Table S3](#SD1){ref-type="supplementary-material"}), while the PKCδ^-^ population contains both regular spiking and late-firing units ([Fig. 1n, o](#F1){ref-type="fig"} and [Table S3](#SD1){ref-type="supplementary-material"}). Thus, PKCδ^+^ neurons have relatively homogeneous electrophysiological properties ([Table S4](#SD1){ref-type="supplementary-material"}, *P* \< 0.0001, Fisher\'s Exact Test).

Functional connectivity of PKCδ^+^ neurons {#S2}
==========================================

To gain genetic access to PKCδ^+^ neurons, transgenic mice were generated^[@R24]^ harboring a bacterial artificial chromosome (BAC) expressing Cre recombinase and the alpha subunit of a CFP-tagged version of the *C. elegans* glutamate-sensitive chloride channel GluCl^[@R25]^ ([Fig. 2a](#F2){ref-type="fig"}), separated by an internal ribosome entry site (ires)^[@R26]^. Double-labeling for GluClα-CFP and PKCδ in these PKCδ:GluClα-ires-Cre mice, as well as crossing to Cre-dependent *lacZ*-expressing reporter mice, revealed neuron-specific expression of the transgene ([Fig. 2j-m](#F2){ref-type="fig"}) that correctly recapitulated the pattern of endogenous PKCδ expression ([Fig. 2b-e, f-i](#F2){ref-type="fig"}).

CEl is known to contain GABAergic neurons that project to CEm^[@R7],[@R12],[@R27],[@R28]^. We traced the anterograde projections of PKCδ^+^ neurons to CEm by injecting the CEl of the transgenic mice with a Cre-dependent adeno-associated virus (AAV) encoding humanized renilla GFP^[@R29]^ (hrGFP) ([Fig. 3a-j](#F3){ref-type="fig"}). Recombination of injected AAVs was restricted to PKCδ^+^ neurons ([Fig. S2f-j](#SD1){ref-type="supplementary-material"}). hrGFP^+^ fibers derived from CEl projected to CEm ([Fig. 3h](#F3){ref-type="fig"}, inset) ([Fig. 3i, j](#F3){ref-type="fig"}), a result confirmed by retrograde tracing from CEm using cholera toxin B-subunit (CTB) ([Fig. 3k, l](#F3){ref-type="fig"}). 60.9±5.7% (mean±S.E.M., *n* = 6) of CTB^+^ neurons in CEl were PKCδ^+^ ([Fig. 3m-o](#F3){ref-type="fig"}, inset white arrowhead), while the remainder were PKCδ^−^.

Freezing is controlled by projections from CEm to the peri-aqueductal gray (PAG)^[@R30]-[@R32]^, but CEm contains multiple neuronal subpopulations with different connectivities^[@R32]^. To determine whether PKCδ^+^ neurons make inhibitory synapses onto PAG-projecting CEm output neurons, we combined whole-cell patch clamp recording of retrogradely-labeled CEm output neurons, with Cre-dependent optogenetic activation^[@R33]^ of PKCδ^+^ neurons ([Fig. 3p, q](#F3){ref-type="fig"}), in acute amygdala slices. Selective expression of channelrhodopsin-2 (ChR2)^[@R34]^ in PKCδ^+^ neurons was achieved by injecting a Cre-dependent AAV encoding ChR2-YFP^[@R35]^ into the CEl of PKCδ:GluClα-ires-Cre transgenic mice ([Fig. S9a](#SD1){ref-type="supplementary-material"}). Whole-cell patch-clamp recordings from ChR2-expressing PKCδ^+^ neurons (identified using native fluorescence for YFP (ChR2) and CFP (GluClα; [Fig. S9b](#SD1){ref-type="supplementary-material"})) confirmed that spiking could be induced with ∼90% efficiency using 473 nm light flashes at 15 Hz ([Fig. S9g](#SD1){ref-type="supplementary-material"}). Retrograde labeling of CEm projection neurons in the same animals was achieved by injection of Alexa-555-conjugated CTB into the PAG ([Fig. 3p](#F3){ref-type="fig"}), permitting their prospective identification using native fluorescence ([Fig. 3q](#F3){ref-type="fig"}, CTB, arrowhead).

In slices prepared from dually injected animals, optogenetic activation of CEl PKCδ^+^ neurons elicited robust, picrotoxin-sensitive IPSCs in CEm output neurons (success rate 100%) ([Fig. 3r, s](#F3){ref-type="fig"}; IPSC amplitude, 18.3±2.3 pA, *n* = 6 cells), with an average latency = 3.7±0.2 ms (range 2-5 ms, *n* = 30) and mean temporal jitter = 0.83±0.16 ms (*n* = 6), consistent with monosynaptic transmission^[@R36]^. It also suppressed current injection-evoked action potentials in CEm output neurons ([Fig. 3t, v](#F3){ref-type="fig"}), in a picrotoxin-sensitive manner ([Fig. 3u, w](#F3){ref-type="fig"}). Thus, CEl PKCδ^+^ neurons make inhibitory connections onto PAG-projecting CEm output neurons.

Light-activation of ChR2-expressing PKCδ^+^ neurons also evoked monosynaptic IPSCs, and suppressed current injection-evoked action potential firing, in CEl PKCδ^−^ neurons (identified by the absence of CFP fluorescence), in a picrotoxin-sensitive manner ([Fig. 4a-g](#F4){ref-type="fig"}). Therefore, PKCδ^+^ neurons also make local inhibitory connections within CEl onto PKCδ^−^ neurons.

To determine whether, conversely, PKCδ^+^ neurons receive inhibitory input from PKCδ^-^ neurons, we employed a cell-specific modification of a virally based mono-synaptic retrograde tracing method^[@R37]^. PKCδ∷GluClα-ires-Cre transgenic mice were first injected with a Cre-dependent AAV encoding both an avian receptor, TVA, and a complementing RV-G protein deleted from the rabies virus strain RV^ΔG^ ([Fig. 4h](#F4){ref-type="fig"}, left)^[@R38]^. Three weeks later, animals were injected in the same site with Env(A)-pseudotyped RV^ΔG^ virus expressing the red fluorescent protein mCherry ([Fig. 4h](#F4){ref-type="fig"}, right; see Methods). Since Env(A) directs infection exclusively to TVA-expressing cells^[@R37]^, this manipulation yields expression of mCherry in CEl PKCδ^+^ neurons in transgenic ([Fig. 4m-p](#F4){ref-type="fig"}; inset, open arrowheads), but not wild-type ([Fig. 4i, j](#F4){ref-type="fig"}) mice. Expression of G by AAV-infected PKCδ^+^ neurons permits trans-synaptic spread of the RV^ΔG^ virus to input neurons, but no further spread occurs^[@R37]^. Monosynaptic retrograde labeling of PKCδ^−^ neurons occurred extensively in CEl ([Fig. 4m, n, p](#F4){ref-type="fig"}; inset, filled arrowheads), and most labeled neurons were GABAergic ([Fig. 4q-t](#F4){ref-type="fig"}; inset, arrowhead). These data suggest that PKCδ^+^ neurons receive inhibitory input from PKCδ^-^ neurons.

PKCδ^+^ neurons correspond to CEl~off~ units {#S3}
============================================

Single-unit recording experiments in freely behaving mice have identified two types of CEl units with opposite responses to the CS^[@R16]^: units activated by the tone ("CEl~on~" cells), and units inhibited by it ("CEl~off~") cells ([Fig. 5i-l](#F5){ref-type="fig"}). We wished to determine whether PKCδ^+^ neurons correspond to either of these classes of units. As the in vivo recordings employ extracellular electrodes^[@R16]^, the cells cannot be filled for antibody staining. Therefore, we examined the effect of reversibly silencing PKCδ^+^ neurons on the activity of CEl~on~ and CEl~off~ units, using a mammalian codon-optimized form^[@R39]^ of the IVM-sensitive chloride channel GluCl from *C. elegans*^[@R14],[@R15]^, mutated to eliminate glutamate sensitivity^[@R25]^. Functional expression of this ionotropic receptor requires two subunits: GluClα and GluClβ. To restrict expression of GluClαβ to CEl PKCδ^+^ neurons, we employed an intersectional strategy in which GluClα--CFP was expressed transgenically in all PKCδ^+^ neurons ([Fig. 2b](#F2){ref-type="fig"}), while GluClβ-YFP^[@R25]^ was expressed in CEl from an AAV vector by stereotaxic injection ([Fig. 5a](#F5){ref-type="fig"}; [S2a-e](#SD1){ref-type="supplementary-material"}).

We first confirmed silencing of PKCδ^+^ neurons using IVM/GluCl in acute amygdala slices from such mice. Neurons expressing GluClα and/or GluClβ could be prospectively identified by native CFP and YFP fluorescence, respectively ([Fig. 5c-e](#F5){ref-type="fig"}). Bath application of IVM reduced the input resistance of cells expressing GluClαβ, but not of cells expressing either GluClα or GluClβ, from 337±41 to 277±36 MΩ (*n* = 4, *P* \< 0.04, paired t-test). IVM also significantly suppressed current injection-evoked spiking in neurons co-expressing both subunits ([Fig. 5c-h](#F5){ref-type="fig"}), as well as sub-threshold EPSPs evoked by bipolar electrode stimulation of LA ([Figure S3](#SD1){ref-type="supplementary-material"}; such bipolar stimulation did not evoke spiking of PKCδ^+^ neurons in our slice preparation).

We next examined the effect of silencing PKCδ^+^ neurons on CEl~on~ and CEl~off~ unit activity^[@R16]^, in PKCδ∷GluClα-ires-Cre transgenic mice previously injected in CEl with the AAV∷GluClβ virus. CEl~on~ and CEl~off~ units were first identified by CS presentation in conditioned animals, prior to IVM administration. The spontaneous spiking activity of these units was subsequently measured before, and 3-5 days after, IVM administration. The tonic activity of CEl~off~ units was strongly suppressed following IVM treatment, while that of CEl~on~ units was unaffected ([Fig. 5m, n](#F5){ref-type="fig"}). This effect of IVM reversed within 48 hrs after treatment ([Fig. 5m](#F5){ref-type="fig"}), and was not observed in IVM-treated uninjected transgenic animals, or in virally injected animals not treated with IVM ([Fig. 5n](#F5){ref-type="fig"}). Importantly, silencing PKCδ^+^ neurons by IVM/GluCl also increased CEm unit activity ([Fig. 5m, n](#F5){ref-type="fig"} red symbols), consistent with our observation that PKCδ^+^ CEl neurons inhibit CEm output neurons ([Fig. 3q-w](#F3){ref-type="fig"}). The simplest interpretation of these data is that CEl~off~ units are PKCδ^+^ neurons, although this does not necessarily imply the converse.

Finally, we tested the effect of suppressing PKCδ^+^ neuronal activity on fear conditioning (see Methods). Because of the slow decay kinetics of IVM in vivo^[@R14]^, we initially investigated the effect of silencing during both training and testing. While IVM at the dose used (10 mg/kg) did not significantly affect freezing in wild-type animals ([Fig. S4a](#SD1){ref-type="supplementary-material"}), to avoid potential interactions between IVM treatment and viral infection, in most experiments single subunit-expressing control animals (transgenic or wild-type animals injected with GluClα or GluClβ virus, respectively) were also treated with IVM. These control groups were not significantly different from each other ([Fig. S4b](#SD1){ref-type="supplementary-material"}) and were pooled for statistical analysis.

In some experiments (n=5-8 animals/group), using a high-titer (10^13^/ml) preparation of AAV2:GluClβ^[@R14]^, a significantly higher level of freezing was observed in experimental animals than in controls; however in other such experiments using different virus preparations, no difference between groups was detected ([Supplementary Footnote 1](#SD1){ref-type="supplementary-material"}). Quantitative histological analysis ([Fig. S10](#SD1){ref-type="supplementary-material"}) revealed considerable variation in the level and bilaterality of GluClβ-YFP expression among individual animals ([Fig. S5a-c](#SD1){ref-type="supplementary-material"}). Therefore, data from multiple experiments (total n=54 animals/group) were pooled for statistical analysis. A Randomized Block ANOVA^[@R40]^ with 6 experimental and 6 control subjects assigned to each of 9 blocks based on infection rate (total n=108; Table 5 and [Fig. S5d-f](#SD1){ref-type="supplementary-material"}) indicated a significant block × group interaction during both the CS presentation (*F*~(8,\ 90)~ = 2.298, P\<0.05 by post-hoc Bonferroni t-test) and post-CS periods (*F*~(8,\ 90)~ = 2.459, *P* \< 0.05), but not the baseline (BL) period (*F*~(8,90)~ = 1.41, *P* = 0.205). Freezing was significantly higher in the experimental group only in the block with the highest infection rate ([Table I](#T1){ref-type="table"}, [Table S5 and Fig. S5e, f](#SD1){ref-type="supplementary-material"}). Freezing in the experimental group was also significantly higher than controls (including GluClαβ animals tested without IVM; n=6) among animals expressing GluClbeta; bilaterally in CEA at a level above the median infection rate ([Fig. S7](#SD1){ref-type="supplementary-material"}). There was no significant decrease in baseline locomotor activity, or in the activity burst produced by the first US presentation during training ([Fig. S8](#SD1){ref-type="supplementary-material"}) in experimental animals, indicating that the increased freezing is not a consequence of either decreased locomotor activity, or increased US-sensitivity^[@R13]^. Freezing levels during the pre-training and pre-test baseline were unaffected by IVM in experimental animals ([Table S5, Figs. S5 and S7](#SD1){ref-type="supplementary-material"} and data not shown).

Discussion {#S4}
==========

We have used genetically based methods to investigate the functional connectivity of a subpopulation of CEl GABAergic neurons identified by expression of PKCδ. Our data suggest that these neurons participate in a recurrent inhibitory circuit within CEl that inhibits CEm output to brainstem centers that control freezing, consistent with earlier suggestions^[@R9],[@R12]^. In the accompanying paper^[@R16]^, Ciocchi et al. identify two populations of CEl units in vivo with opposite responses to the CS. The data presented here strongly suggest that CEl~off~ units are PKCδ^+^ neurons, linking molecular and physiological identity. Because PKCδ^+^ neurons pre-exist in untrained animals, this linkage suggests that CEl~off~ and CEl~on~ units, which are robustly identifiable after conditioning ([Fig. 5k, l](#F5){ref-type="fig"}), arise via plasticity-dependent changes in deterministic CEl subpopulations, rather than by stochastic selection from a population of initially homogeneous cells.

The link between PKCδ^+^ neurons and CEl~off~ units is also consistent with complementary connectivity data in the two studies. For example, Ciocchi et al. have shown that in vivo, the activity of CEl~off~ units is inversely correlated with the activity of CEl~on~ units, suggesting reciprocal inhibition^[@R16]^. Our channelrhodopsin-assisted circuit mapping^[@R36]^ and cell-specific monosynaptic retrograde viral tracing^[@R37]^ data directly demonstrate mutual inhibitory connections between PKCδ^+^ and PKCδ^−^ neurons in CEl. Ciocchi et al. have also shown that CS exposure both inhibits CEl~off~ unit spiking, and increases CEm unit activity^[@R16]^, with a short latency implying an inhibitory connection. Our data directly demonstrate inhibitory synapses from CEl PKCδ^+^ neurons onto brainstem-projecting CEm output neurons, and indicate that silencing the former increases the tonic activity of the latter in vivo. Thus, our direct mapping of PKCδ^+^ synaptic connectivity in amygdala slices is consistent with inferences of CEl~off~ unit connectivity based on correlative in vivo recordings ([Fig. 5b](#F5){ref-type="fig"}).

Consistent with these electrophysiological and connectional data, genetic silencing of PKCδ^+^ neurons yielded a statistically significant enhancement of conditional freezing (during both the CS-on and post-CS periods), among those animals exhibiting the highest level of AAV∷GluClβ infection in CEl. Nevertheless, these behavioral results should be interpreted with caution, given the variability in results between individual experiments (see [Supplementary Footnote 1](#SD1){ref-type="supplementary-material"}). Furthermore, while IVM treatment caused a decrease in CEl~off~ tonic spiking activity in GluClαβ -expressing animals, how this effect influences CS-evoked freezing, which is correlated with phasic CS-response in CEl~off~ unit activity^[@R16]^, is not yet clear.

While the CEl circuitry defined by this study and Ciocchi et al.^[@R16]^ is remarkably consistent, the behavioral results in the two studies differ in some respects. For example, muscimol injection into CEl evoked freezing in unconditioned animals^[@R16]^, while selective silencing of PKCδ^+^ neurons using IVM/GluCl did not. Furthermore, transient inhibition of CEl during training using muscimol attenuated fear conditioning^[@R16]^, while chronic silencing of PKCδ^+^ neurons during both training and testing did not. We have not yet examined the behavioral effects of silencing PKCδ^+^ neurons during training vs. testing, and this will be an important question for future studies. Differences in the consequences of muscimol inhibition of CEl vs. IVM/GluCl silencing of CEl PKCδ^+^ neurons may reflect differences in the cellular specificity, efficiency or time-course of the two types of manipulations ([Supplementary Footnote 2](#SD1){ref-type="supplementary-material"}).

The CEl/CEm micro-circuit revealed by these companion studies has interesting properties worthy of further investigation. For example, the mutual inhibitory connections between CEl~off~ and CEl~on~ units could provide a positive-feedback loop to amplify CS-evoked activity in CEl~on~ units ([Fig. 5b](#F5){ref-type="fig"})^[@R41]^. These antagonistic connections could also potentially encode different states, through stable imbalances in tonic activity^[@R16]^, or different oscillatory regimes, that could influence the learning and/or expression of conditioned fear. A currently unresolved paradox is why, if CEl~on~ units (like CEl~off~ units) send inhibitory projections to CEm^[@R16]^, activation of CEl~on~ units by the CS results in increased rather than decreased activity of CEm output neurons (see [Supplementary Footnote 3](#SD1){ref-type="supplementary-material"}). Resolution of this paradox will require distinguishing whether these two CEl populations target the same or different classes of CEm neurons^[@R32]^, and the relative strength of these connections. Genetically based synaptic tracing and functional manipulations of CEl~on~ units should clarify this issue, as well as provide direct tests of their causal role in conditioned freezing and other emotional behaviors. The ability to prospectively identify and selectively manipulate PKCδ^+^ and other molecularly defined CEl subpopulations^[@R42],[@R43]^ should also open the way to investigating their roles in animal models of phobic or anxiety disorders, and in the mechanism of action of drugs used to treat such disorders^[@R44]^.

Methods Summary {#S5}
===============

Histochemical methods {#S6}
---------------------

Single color and double fluorescent ISHs were performed on fresh frozen sections, using DIG (Roche) and DNP (Perkin Elmer) labeled RNA probes. Immunofluorescence was carried out on cryosections of 4 % PFA perfused tissue following standard protocols.

Generation of PKCδ∷GluClα-ires-Cre transgenic mice {#S7}
--------------------------------------------------

A GluClα-ires-Cre cassette was inserted into PKCδ BAC clone RP23-283B12 (CHORI). The modified BAC was injected into FVB mouse embryos (GENSAT). Transgenic founders were backcrossed (*n* \> 5) to C57Bl6/N. These mice are available through GENSAT^[@R24]^.

Pharmacogenetic silencing in vitro and in vivo {#S8}
----------------------------------------------

PKCδ∷GluClα-ires-Cre transgenic or wild-type mice were injected with ∼10^9^ particles of AAV∷GluClβ (or, in control experiments, AAV∷GluClα) into CE and allowed 4 weeks for recovery. For fear conditioning experiments, on day 1, mice were habituated and then injected with IVM (10 mg/kg (Phoenix)). On day 2, animals received tone/foot shock pairings in context A (Coulbourn, Med Associates). On day 3, (and for in vivo recordings also on days 6 and 8), animals were placed in context B and freezing was scored prior to (baseline), during and after CS presentations. For in vitro recordings, acute brain slices were prepared and superfused with 20 nM IVM in ACSF to induce pharmacogenetic silencing. Single-unit recordings were performed in freely behaving animals as described^[@R16]^.

Optogenetic circuit dissection {#S9}
------------------------------

PKCδ∷GluClα-ires-Cre transgenic mice were injected with 10^9^ particles of Cre-dependent ChR2 AAV into CE, and (in some animals) CTB into PAG for retrograde labeling. Four weeks later, neurons were light-stimulated, in acute brain slices, through a 200 μm optical fiber (Thorlabs) emitting 5-10 mW 473 nm laser light (Crystalaser).

Virus based transsynaptic tracing {#S10}
---------------------------------

PKCδ∷GluClα-ires-Cre transgenic mice were sequentially injected into CE with 10^4^ particles of AAV encoding Cre-dependent TVA and rabies B19 glycoprotein (G). Three weeks later, animals were injected in the same site with 10^5^ particles of RV^ΔG^ rabies virus pseudotyped with EnvA, and analyzed 1 week later. All animal experiments were conducted under protocols approved by the Caltech Institutional Animal Care and Use Committee (IACUC) and the Salk Institute Biosafety Committee.

Methods {#S11}
=======

Generation of PKCδ∷GluClα-iCre transgenic mice {#S12}
----------------------------------------------

The PKCδ∷GluClα-iCre targeting construct was assembled in pGEM-T Easy (Promega) by PCR-cloning nucleotides -425 to -1 (+1 corresponding to the PKCδ start codon, primer set 5′-ACACACCGCGGCGCGCCCTAAAGAGGCAGGAGGCATGTG and 5′-CCATGATGGAGCCTGGAGTGAG) and +4 to +561 (primer set 5′-TCTCTGCTAGCCCGGGACCCTTCCTGCGCATCTC and 5-TGTGTGGTCGACTTAATTAAACTAGTGACCTTTCCAGCCATCACGTG) of PKCδ genomic sequences 5′ and 3′ to the GluCl-α open reading frame (ORF)^[@R39]^, using Ksp I-blunt/Mlu NI and Nhe I-Sal I restriction sites, respectively. The resulting PKCδ∷GluClα cassette was then cloned into the pLD53 shuttle vector ^[@R45]^. An additional expression cassette containing the Encephalomyocarditis virus internal ribosome entry site (IRES) followed by an ORF coding for Cre-recombinase was cloned into the Nhe I site immediately downstream GluClα. This vector was then used to introduce the GluClα-iCre expression cassette into a bacterial artificial chromosome (BAC) clone containing the complete PKCδ gene (RP23-283B12) by Rec A-mediated homologous recombination in bacteria ^[@R45]^ (for final sequence see [Supplementary Information](#SD1){ref-type="supplementary-material"}). Homologous recombination was verified by PCR (5′ arm primer set 5′-AGACCAGGGTAGGAGTCGGTG and 5′-GATCAGGGAAGCGATGATCAG, 3′ arm primer set 5′-GAGACCAAGACCGAGTGGAA and 5′-CACAGGTTAGCCATGACCTG) and southern blotting (5′ arm probe primer set 5′-TGTTCATGGGGTTTCTCACAG and 5′-ACCGACTCCTACCCTGGTCAG, 3′ arm probe primer set 5′-AGGTCATGGCTAACCTGTGG and 5′-GGCAGAGAAGTCAGACTGGG). Transgenic mice were generated by pronuclear injection of CsCl prepared BAC DNA linearized with P-Sce I in FVB embryos ^[@R24]^, which yielded two independent transgenic lines with indistinguishable expression pattern. One of them was backcrossed for n\>5 generations to C57Bl6/N. Germ line transmission and genotyping of transgenic offspring were traced by PCR on genomic tail DNA (primer set 5′- GCTACATCAAGGCCATCGAC and 5′- AACTCCAGCAGGACCATGTGATCG).

In situ hybridizations {#S13}
----------------------

ISH was performed on 20 μm fresh frozen brain sections.

Processing of sections, hybridization and probe detection for single color in situ hybridizations were carried out following standard protocols ^[@R19]^, with the following specifications: Probes were cloned from whole mouse brain cDNA library (Invitrogen; GAD65 primer set 5′-ATCTCCAACATGTATGCCATGCTCATTGCC and 5′-TTACAAATCTTGTCCGAGGCGTTCGA, CRH primer set 5′-AACGGAGTAAGGGCAGGAATGGAGACAGAG and 5′-GTTGCTGTGAGCTTGCTGAGCTAACTGCTCTGC, Enk primer set 5′-TAGGGTCCAAGCTCTCATTGAGGCACCCGG and 5′-GCTTCAGAACCGCATAAAGCCCCCGTAT, OxtR 5′-CTGGCCCACCAGGCCAGCCGCTGGGTGGTG and 5′-AATCCCCATCTCCTTGGGAATTTTAGGAT) transcribed from linearized templates in pTeasy (Promega) or pCR2.1 (Invitrogen) using Sp6 (9PIP108, Promega) or T7 (9PIP207, Promega) polymerase and Digoxigenin labeled nucleotide mix (11277073910, Roche), used at a final concentration of 1 μg/ml, and detected with Anti-Dig-HRP, Fab fragments (1-207-733, Roche).

Processing of sections and hybridization for double fluorescence ISH was carried out as above, with the following specifications: DIG and DNP-UTP (NEL555001, Perkin Elmer) probe pairs were used at a final concentration of 1 μg/ml each. For detection, sections were blocked first in 20 % sheep serum in 0.1M Tris-HCl, pH7.5, 0.15M NaCl, 0.05% Tween-20 and NEN-Blocking solution (Perkin Elmer) for 30 min, each. DIG labeled probe was detected with anti-DIG Horseradish peroxidase (POD) (1: 500, 2h), Biotin-Tyramide (1:100, 8 min, RT, Perkin Elmer), Vecta Stain Elite ABC Kit (*Vector* PK-6100) and Cy3-Tyramide (Cy3 Tyramide NEL704A, PerkinElmer, 1: 50, 1h). Horseradish peroxidase was inactivated by incubation in 3 % H~2~O~2~ in PBS (1 h), followed by heat denaturation in TE (5 min, 85 C). Sections were blocked again as above and DNP-labeled nucleotides were detected with anti-DNP Horseradish peroxidase (1:500, 2h), DNP-Tyramide, anti-DNP Horseradish peroxidase (1:500, 2h, all TSA DNP Kit, NEL747A, PerkinElmer) and Fluorescein-Tyramide (1: 100, NEL701, PerkinElmer). Sections were mounted in Fluoro Gel (17985-10, Electron Microscopy Sciences). All washing steps and incubations were carried out according to the respective manufacturers\' recommendations. Sections were visualized on Zeiss Axioscope, and Leica TCS SP confocal, microscopes.

Immunofluorescent labelling {#S14}
---------------------------

For IFL, mice were transcardially perfused with 4 % paraformaldehyde in PBS. Brains were removed and cryoprotected in 15 % sucrose (16 h, 4 C). 20-30 μm cryo-sections were air dried for 30 min, rehydrated in PBST (PBS + 0.1 % Trition-X-100). In some instances, immunoreactivity was increased by incubating the slides in 10 mM Sodium citrate, 0.05 % Tween-20, pH 6 for 10 min at 95 C. Non-specific binding was blocked with 1 % BSA in PBST for 30 min. Primary antibodies, diluted 1:300-1000 in blocking solution (mouse anti PKCδ, 610398 BD Biosciences; Guinea Pig anti Dynorphin, GP10110 Neuromics; rabbit anti GFP A11122, Invitrogen; rabbit anti hrGFP 240142, Stratagene; Mouse anti NeuN MAB377, Chemicon) were incubated at for 16 h at 4 °C. Standard secondary antibodies (Invitrogen) in blocking solution were incubated for 3 h at RT. Unbound primary and secondary antibody was each washed by incubating three times in PBST for 10 min. Sections were mounted in Fluoro Gel (17985-10, Electron Microscopy Sciences) and visualized on Zeiss Axioscope, and Leica TCS SP confocal, microscopes.

Animal Maintenance {#S15}
------------------

Animals were group housed at 23 C with *ad libitum* access to food and water in a 13 h day, 11 h night cycle, day starting at 7 AM.

Histological analysis {#S16}
---------------------

All histological quantifications ([Fig. 2i, m](#F2){ref-type="fig"}, [S2e, j, S5, S7, S10 and Tables S1, S5](#SD1){ref-type="supplementary-material"}) are based on at least three coronal sections spaced equidistantly along the rostro-caudal axis of CE.

The intrinsic fluorescence of GluClα−CFP, or GluClβ-YFP can be readily detected in live brain slices ([Fig. 4a](#F4){ref-type="fig"}, [5c-e](#F5){ref-type="fig"}, [S9a, b](#SD1){ref-type="supplementary-material"}). In the perfusion fixed tissue used for all histological analysis, however, the fluorescent signal is substantially weaker. Therefore, GFP IFL directed against its C/YFP tag was used wherever possible for more accurate results ([Fig. 1b-h, 1j-l](#F1){ref-type="fig"}, [S2b-d, S5](#SD1){ref-type="supplementary-material"}). However, this immunohistochemical method could not be used to quantify the extent of infection by AAV∷GluClβ-YFP in PKCδ∷GluClαCFP-iCre transgenic mice, because of cross-reactivity of the anti-GFP antibody with the transgene-encoded CFP. Therefore, the fraction of virally infected PKCδ^+^ neurons in PKCδ∷GluClαCFP-iCre transgenic brains was estimated by quantifying the number of cells expressing intrinsic YFP fluorescence (which could be spectrally distinguished from the endogenous CFP-fluorescence of the GluClα transgene). However, because this intrinsic fluorescence signal underestimates the extent of viral infection in perfusion-fixed tissue (see above), we constructed a standard curve using wild-type mice infected with AAV:GluClβ-YFP virus, in which the number of infected cells measured using native YFP fluorescence was plotted against the number of infected PKCδ^+^ cells measured using double-immunofluorescence staining with anti-GFP and anti-PKCδ antibodies ([Fig. S10](#SD1){ref-type="supplementary-material"}). This standard curve was then used to estimate the fraction of PKCδ^+^ cells that would have been detectable by direct immunofluorescence labeling for GFP, based on quantification of native YFP fluorescence. In the behavioral experiments in which wild-type and PKCδ∷GluClα- CFP-iCre transgenic animals were classified based on their infection rates ([Table S5](#SD1){ref-type="supplementary-material"}, [Table I](#T1){ref-type="table"}, [Fig. S5, S7](#SD1){ref-type="supplementary-material"}), this estimation method was applied to all experimental groups, including wild-type animals.

Electrophysiological slice recordings {#S17}
-------------------------------------

Standard mouse brain slice preparation and whole cell recording were performed as described^[@R14]^. Briefly, 250 μm thick coronal sections were prepared with a vibratome (VT1000S, Leica), using ice-cold glycerol-based artificial cerebrospinal fluid (gACSF, in mM: 252 glycerol, 1.6 KCl, 1.2 NaH~2~PO~4~, 1.2 MgCl~2~, 2.4 CaCl~2~, 18 NaHCO~3~, and 11 glucose, oxygenated with 95%O~2~/5%CO~2~). Slices were allowed to recover for at least 1 hour at 32°C and kept at room temperature in standard artificial cerebrospinal fluid (ACSF, in mM: 126 NaCl, 1.6 KCl, 1.2 NaH~2~PO~4~, 1.2 MgCl~2~, 2.4 CaCl~2~, 18 NaHCO~3~, and 11 glucose, oxygenated with 95%O~2~/5%CO~2~). Cells expressing CFP or YFP were visualized by infrared DIC and fluorescence video microscopy (Olympus BX51). Whole-cell voltage and current recordings were performed at 30 °C with a MultiClamp 700B amplifier and Digidata 1440A (Molecular Devices, Sunnyvale, CA). The patch pipette with a resistance of 5-8 MΩ was filled with an intracellular solution containing (in mM): 135 Potassium gluconate, 5 EGTA, 0.5 CaCl~2~, 2 MgCl~2~, 10 HEPES, 2 Mg-ATP, and 0.1 GTP, PH 7.2, 280-300 mOsm. Data were sampled at 10 kHz, filtered at 3 kHz and analyzed with pCLAMP 10 software.

Electrophysiological characterization of PKCδ^+^ cells {#S18}
------------------------------------------------------

The relation of genetic marker and electrophysiological type was analyzed using Fisher\'s exact test with the null hypothesis that PKCδ^+^ cells have the same proportion of late-firing neurons as do CEl neurons as a whole. We recorded 38 CEl neurons without knowing their genetic subtypes, 21 of which were late-firing neurons. 14 of the17 non late-firing neurons were regular-spiking, 3 low-threshold bursting cells ([Table S2, S3](#SD1){ref-type="supplementary-material"}). We also recorded 57 PKCδ^+^ neurons based on their CFP expression, and found 49 of them are late-firing neurons, 8 of them are non late-firing neurons (all 8 cells are regular-spiking cells; [Table S4](#SD1){ref-type="supplementary-material"}). Fisher\'s exact test revealed that PKCδ^+^ neurons have a relatively homogeneous electrophysiological property of late-firing neurons compared to CEl neurons as a whole.

Stereotaxic surgery {#S19}
-------------------

2-4 months old male mice were deeply anesthetized with either ketamine/xylazine or isoflurane, injected i. p. with 500 μl 20 % mannitol (Phoenix pharmaceuticals), and placed in a stereotaxic frame (Kopf). The skull was exposed and perforated using a stereotaxic mounted drill at the desired coordinates ([Table S6](#SD1){ref-type="supplementary-material"}). For post-operative care mice were injected i. p. with 2 mg/kg BW ketoprofen, and supplied with drinking water containing 80 mg/l Trimethoprim, 400 mg/l sulfamethoxazole and 200 mg/l Ibuprofen for 10 days.

Viral injections {#S20}
----------------

Viral particles were delivered unilaterally by stereotaxic (see above) injection with through stereotaxic mounted motor driven 32 G 45 degree beveled steel cannulas (Micro 4 controller equipped with Hamilton system, World Precision Instruments) or glass capillaries (Micro4 controller equipped with Microject system, Word Precision Instruments) to 1-4 injection sites/hemisphere at flow rates of 50-100 nl/min.

Pharmacogenetic silencing in vitro {#S21}
----------------------------------

Mice were unilaterally injected with a total of 2 μl AAV GluClα or -β virus (serotype 2; 1-10 × 10^12^ particles/ml in PBS) into CE (see above). Four weeks after surgery, slices (see above) were perfused with 20 nM IVM in ACSF for 20 min to induce pharmacogenetic silencing.

Pharmacogenetic silencing in vivo {#S22}
---------------------------------

Mice were injected bilaterally with a total of 2 μl AAV GluClα or -β virus (serotypes 2, 5, 8; 1-10 × 10^12^ particles/ml in PBS) into CE (see above). Four weeks after surgery, on day 1, animals were habituated 20 min to context A and given single i. p. dose of 1 % IVM injectable solution (Phoenix) at 10 mg/kg BW, or vehicle. On day 2, animals were fear conditioned in context A connected to a shock scrambler (Coulbourn Instruments, Allentown, PA; Med Associates, St. Albans, VT). After 20 min mice were exposed to training trials of 85 dBA 2 kHz 20 s tone immediately followed by a 2 sec 0.5 mA foot shock with 198 sec inter-trial interval (ITI). To avoid masking of the consequences of the experimental manipulation by ceiling and floor effects, the number of training trials (3-6) was adjusted such that freezing levels averaged around 50 % in the genetic/viral control. During the training session, behavior was recorded with infrared sensors (Coulbourn Scientific) or video cameras (Med Associates). On day 3, mice were placed in context B, differentiated from context A by a modified wall, floor and ceiling. Before each trial, all surfaces were cleaned with water and disinfectant. After a 5 min baseline period, two test trials of a 30 s CS followed by a 1 min post-CS period were presented. Freezing was scored either manually by an observer blind to the experimental group of the animal (Coulbourn Scientific), or electronically (Med Associates). Freezing during the CS and post-CS periods are represented as bins of these two test trials. Baseline freezing was averaged over 3 min before the first CS presentation.

To investigate the relationship between freezing and the extent of viral infection ([Fig. S5, a-c](#SD1){ref-type="supplementary-material"}), freezing data were correlated with the fraction of PKCδ^+^ expressing GluClβ, estimated as described above using native fluorescence for YFP and the standard curve in [Fig. S7](#SD1){ref-type="supplementary-material"}.

To investigate differences in freezing between experimental and control groups, freezing in the experimental group was compared to genetic/viral control groups by 2-way ANOVA with infection rate as blocking variable ([Table S5, Fig. S5, d-f](#SD1){ref-type="supplementary-material"}).

Retrograde tracing with CTB {#S23}
---------------------------

CTB (0.5 % in PBS; List) was delivered by stereotaxic (see above) iontophoresis with a positive-pulsed current of 5 μA for 2 min. The animals were sacrificed one week post-injection, and the brains were processed for IHC.

Optogenetic circuit dissection {#S24}
------------------------------

Mice were unilaterally injected with a total of 2 μl or Cre-dependent AAV ChR2 virus (serotypes 2, 5; 1-10 × 10^12^ particles/ml in PBS) into CE (see above). Slices (see above) were stimulated with an optic fiber (200 μm core diameter, ThorLabs), coupled to a 473 nm laser (CrystaLaser) and mounted on a 3-D micromanipulator (MPC365, Sutter) with the fiber end positioned on the edge of CEl.

Cre-dependent monosynaptic tracing with Rabies virus {#S25}
----------------------------------------------------

Cre-expressing cells were primed for subsequent infection and monosynaptic retrograde spread of EnvA-pseudotyped, glycoprotein gene-deleted rabies virus, by stereotaxic injection (see above) of 180 nl of Cre-dependent AAV expressing the avian receptor protein TVA and rabies B19 glycoprotein (AAV9-pEF1α-FLEX-GTB) into CE. The genomic structure of AAV9-pEF1α-FLEX-GTB is: L_ITR-EF1α Pro-Kozak-(FLEX cassette^[@R46]^ containing GFP-T2A-hTVA-E2A-hB19G)-STOP-WPRE-polyA-R_ITR. The start ATG has been deleted from all three genes, and transcription start is mediated by a Kozak sequence that precedes the FLEX cassette ^[@R47]^. Genes were linked together through the use of 2A elements, which allow for the expression of multiple genes under the control of a single promoter^[@R48],[@R49]^. Both the TVA and B19G genes were codon-optimized for expression in mammalian cells. The virus was prepared through a crude lysate extraction of transfected 293T cells, and has a genomic titer of 10^8^ particles/ml. Although reverse-complemented GFP is detectable in the AAV genome, Cre-expressing cells expressed undetectable levels of GFP, either through native fluorescence or antibody-amplified imaging, while TVA and B19G appear to express normally.

Three weeks later, mice were injected at the same site with 180 nL of glycoprotein gene-deleted rabies virus ^[@R50]^ that has been pseudotyped with the avian sarcoma leucosis virus glycoprotein EnvA ^[@R38]^. The glycoprotein gene has been replaced with mCherry. The resulting virus, (EnvA)SAD-dG-mCherry, is incapable of infecting mammalian neurons in the absence of its binding partner, TVA, and cannot spread retrogradely in the absence of the rabies B19 glycoprotein ^[@R37]^. The biological titer of 10^9^ particles/ml was determined through infection of TVA-expressing 293T cells. One week after the second injection, the animals were sacrificed and the brains processed for IHC.

Pharmacogenetic silencing with *in vivo* electrophysiological recordings {#S26}
------------------------------------------------------------------------

Mice were injected bilaterally with a total of 2 μl AAV GluClα virus (serotypes 2; 1-10 × 10^12^ particles/ml in PBS) into CE (see above). Four weeks later, on day 1, mice were habituated to 4 CS presentations (total CS duration of 30 s, consisting of 50-ms pips repeated at 0.9 Hz, 2-ms rise and fall; pip frequency: 7.5 kHz, 80 dB sound pressure level) in context B. On day 2, mice were conditioned with 5 CS/US (0.6 mA, 1 s) pairings with ITIs of 20-180 s in context A (Coulbourn). On days 3, 6, 8, mice were exposed to 4 CS presentations in context B. During these periods, individual neurons were recorded extracellularly in freely behaving mice. Spikes of individual neurons were sorted by time-amplitude window discrimination and template matching as previously described^[@R51],[@R52]^. Cluster quality was verified by quantifying the cluster separation^[@R52]^ ([Fig. S8](#SD1){ref-type="supplementary-material"}). Unit isolation was verified using auto- and cross-correlation histograms. Spike rasters and histograms were constructed by aligning sweeps relative to the CS onset, and CS-evoked responses were normalized to baseline activity using a *z*-score transformation. Detailed methodological information about *in vivo* single unit recordings of CE neurons is presented in Ciocchi et al..

Supplementary Material {#S27}
======================
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![Characterization of CEl PKCδ^+^neurons\
**a**, *In situ* hybridization (ISH) for PKCδ mRNA. CA3, hippocampus; Thal, thalamus. Boxed area at higher magnification on right. **b-j**, Double-label fluorescence ISH (dFISH) for PKCδ mRNA and the indicated markers. Insets, boxed areas. Filled and open arrowheads indicate doubly vs. singly labeled cells, respectively. **k-l**, Whole-cell patch clamp recordings in acute amygdala slices. Voltage changes (red) produced by respective current injections (black) are illustrated. Resting membrane potentials were adjusted to ∼ -65 mV. **m, n**, Neurobiotin-filled CEl neurons recorded in (**k, l**) after fluorescent streptavidin labeling and immunostaining for PKCδ. **o**, Stimulus-response (I/O) curves for neurons based on electrophysiological profile (late-firing, *n* = 22; regular spiking, *n* = 14), or PKCδ expression (PKCδ^+^, *n* = 14; PKCδ^-^, *n* = 12) in CEl. See also [Tables S2-S4](#SD1){ref-type="supplementary-material"}.](nihms243118f1){#F1}

![Transgenic targeting of PKCδ^+^neurons\
**a**, Design of PKCδ∷GluClα−CFP-iCre BAC transgene. **b-d, f-h, j-l**, Expression of transgene visualized by double-label immunofluorescent labeling (dIFL) for GFP and the indicated markers. **i, m**, Quantification of **f-h** and **j-l**, respectively. Values are mean ± SEM, *n* = 3. (**e**) X-gal staining of PKCδ∷GluClα-iCre; Rosa∷loxP-STOP-loxP-lacZ mice reveals β-galactosidase expression (blue) in correct locations. Scale bar in **b** applies to **c-h** and **j-l**.](nihms243118f2){#F2}

![CEl PKCδ^+^neurons directly inhibit CEm output neurons\
**a-j**, Anterograde axonal tracing using Cre-dependent hrGFP AAV^[@R29]^. **k-o**, Retrograde tracing from CEm using red fluorescent CTB. Scale bars for **b-j, l-m**, respectively. **p-w**, Optogenetic activation of CEl PKCδ^+^ neurons inhibits PAG projecting neurons in CEm. **p**, Schematic illustrating double-injection/slice recording experiments. **q**, CTB^+^ CEm cell (CTB, arrowhead) with patch electrode (IR DIC, dashed lines) is illustrated. **r-v**, Whole-cell voltage-clamp (V~hold~ = -40 mV) (**r, s**) or current clamp (**t-v**) recordings from a back-labeled CEm neuron. **r**,**s**, IPSC triggered by a 2 ms 473 nm laser pulse, with (**s**) or without (**r**) 100 μM picrotoxin. **t-v**, suppression of depolarizing current injection-evoked spiking by 473 nm laser pulses (2 ms, 15 Hz), with (**u**) or without (**t**) 100 μM picrotoxin. **v, w**, Quantification of data in **t** (*n* = 5 cells; \* *P* \< 0.001, t-test) and **v** (*n* = 3 cells; *P* = 0.75, t-test), respectively.](nihms243118f3){#F3}

![PKCδ^+^and PKCδ^-^ make reciprocal inhibitory connections in CEl\
**a**, Schematic and micrograph from slice preparation. Arrowhead indicates PKCδ(CFP)^minus;^ (YFP)^-^ recorded cell in CEl. **b-e**, Whole-cell voltage clamp (V~hold~ = -40 mV) (**b, c**) or current clamp (**d, e**) recordings from PKCδ^-^ CEl neuron showing light-triggered (**d**), picrotoxin-sensitive (**c**) IPSC, or picrotoxin-sensitive (**e**) suppression of depolarizing current injection-evoked spiking (**d**) by ChR2 activation (blue dots; 2 ms, 15 Hz). **f, g**, Quantification of data in **d** (**f**; *n* = 5 cells, \*\*\* *P* \< 0.001, t-test) and **e** (**g**; *n* = 3 cells, *P* = 0.66, t-test), respectively. **h**, Schematic illustrating cell-specific Rabies virus infection. **i-p**, immunostaining for PKCδ(**i,m**), intrinsic mCherry fluorescence (**j, n**) and nuclear staining with TOPRO-3 (**k, o**) 3 days after RV^ΔG^ injection of transgenic (**m-p**) and wild-type (**i-l**) mice. Primary infected PKCδ^+^ neurons (**m, n** insets, open arrowheads) and retrogradely labeled PKCδ^-^ cells (**m, n** insets, filled arrowheads) are indicated. **q-t**, Triple labeling for PKCδ (**q**) and GABA (**s**) and mCherry (**r**). mCherry-labeled PKCδ^-^ cells are GABAergic (inset, arrowhead). Scale bars for **f-m, n-q.**](nihms243118f4){#F4}

![IVM/GluCl-mediated suppression of CEl PKCδ^+^neuronal activity\
**a**, Strategy for selective expression of GluClαβ in CEl PKCδ^+^ neurons. Yellow, CMV-driven AAV∷GluClβ virus; blue, PKCδ∷GluClα-CFP transgene expression. **b**, Summary of inhibitory connections in CEA (see also Ciocchi et al^[@R16]^). **c-e**, Current injection (bottom trace)-evoked spiking (top, black trace) is suppressed by 20 nM IVM (middle, red trace) in PKCδ^+^ cells expressing GluClαβ (**c**), but not in cells expressing either GluClβ-YFP (**d**) or GluClα-CFP (**e**). **f-h**, Quantification of results in **c-e**, respectively (**f**, *n* = 4 cells, *P* = 0.005); **g**, *n* = 5 cells, *P* = 0.73; **h**, *n* = 4 cells, *P* = 0.66; paired t-tests). **i-n**, IVM/GluCl-mediated silencing of PKCδ^+^ neurons during chronic *in vivo* recording. **i**, Behavioral data for mice used in recording experiments. Hab, habituation; FC, fear conditioning. (*n* = 5) **j**, Coronal schematic showing recording sites in CEl and CEm (-1.34 mm posterior to bregma). BLA: basolateral amygdala. **k, l** Representative raster plots (upper) and normalized population peristimulus time histograms (lower) of CEl~off~ (**k**; lower, *n* = 6 neurons from 3 mice) and CEl~on~ neurons (**l**; lower, *n* = 10 neurons from 4 mice) (*P* \< 0.05). Confirmation of unit isolation is shown in [Figure S11](#SD1){ref-type="supplementary-material"}. **m**, Tonic activity of CEl~off~ neurons (One-way ANOVA (*F*~(2,15)~ = 4.845, *P* = 0.024) with post-hoc Bonferroni t-test (\* *P* \< 0.05), but not of CEl~on~ neurons (One-way ANOVA (*F*~(2,27)~ = 0.391, *P* = 0.680)), is significantly (Day 6) and reversibly (Day 8) reduced by IVM (10 mg/kg, i.p.), while tonic activity of CEm neurons is increased (*n* = 5 units from 1 mouse; one-way Kruskal-Wallis ANOVA (*H* = 7.487, with 2 degrees of freedom, *P* = 0.024) with post-hoc Tukey\'s HSD (\* *P* \< 0.05)). **n**, Specificity controls for (**m**). IVM injection without virus infection (*n* = 3; *P* = 0.765); vehicle (DMSO) injection with AAV2∷GluClβ virus infection (*n* =5; *P* = 0.940). CEl~on~ neurons (*n* = 10; *P* = 0.497); CS-non responsive neurons (*n* = 9; *P* = 0.644). \**P* \< 0.05 (paired t-tests with vs. without IVM in virus-injected mice).](nihms243118f5){#F5}

###### Behavioral effect of silencing PKCδ^+^ neurons in CEl

  Group (Block 9)                    Inf. Rate^a^ (%)   BL Freezing (%)   CS Freezing (%)         Post-CS freezing (%)
  ---------------------------------- ------------------ ----------------- ----------------------- ------------------------
  Control (GluClα or GluClβ + IVM)   40.0±0.8           5.8±2.2           49.4±10.4               19.2±6.0
  Experimental (GluClαβ +IVM)        40.6±3.5           2.6±1.5 (n. s.)   91.1±4.7 (*P* \< .05)   75.3±8.4 (*P* \< .001)

The data are derived from the Randomized Block ANOVA in [Table S5](#SD1){ref-type="supplementary-material"} (total n=108; 6 experimental and 6 control animals assigned to each of 9 blocks), and illustrate the block with the highest level of viral infection in CEl (^a^Infection Rate, % of PKCδ^+^ cells expressing GluClβ-YFP; see [Fig. S10](#SD1){ref-type="supplementary-material"}). The control group is pooled ([Fig. S4b](#SD1){ref-type="supplementary-material"}) single subunit-expressing mice (GluClα or GluClβalone) treated with IVM. Values represent the mean±S.E.M. n.s., not significantly different. *P* values are from post-hoc Bonferroni t-test. A significant linear component to the block × group interaction indicated that the difference between groups tended to increase with infection rate (*F*~(1,90)~ = 22.98, *P* \< 0.0001 for CS, *F*~(1,\ 90)~ = 8.85, *P* \< 0.006 for post-CS). See also [Table S5 and Figure S5](#SD1){ref-type="supplementary-material"}. Control GluClαβ-expressing mice not treated with IVM were significantly different from the experimental group among animals exhibiting bilateral AAV infection above the median rate (n=6-21; [Fig. S7](#SD1){ref-type="supplementary-material"}).

[^1]: These authors made equal contributions
